Protocol-Driven, Customized Site Solution Strategy

Accelerate study start-up with the right sites, patients, and partnerships

As protocols become more complex and sites face new pressures, your site selection strategy needs to be more nuanced than ever before. At Parexel, we bring that nuance and precision with the help of our Site Alliance Strategists, Community Alliance Network and Launch Excellence Office — a team who are committed to launching your projects quickly and efficiently with expertise in all key functions in clinical development strategy, planning, oversight, and delivery execution.

The right sites for the right patient population

Our aim is to ensure that protocols target the right patient population and minimizing the impact on their daily life while meeting the scientific needs of the study. Successful patient recruitment starts with selecting the right sites. Every protocol presents different challenges, depending on the therapeutic area, research objectives and target patients, and we address these challenges with a site profile informed by various formulae and models through our Site and Community Alliance Networks and expertise.

Your input drives success

To inform protocol design in the early stages of development, we invite investigative site staff — key opinion leaders who are walking alongside patients and their families every day — to provide input . Getting this feedback on protocol design from those closest to the patient sets the protocol up for success – reducing patient burden, improving retention, minimizing change orders, etc. Study staff can alert us to and help us address barriers to recruitment and retention at the earliest stages.

Before the protocol is fully set, we can provide feedback about how to incorporate community partners in the site strategy via our Community Alliance Network. The Community Alliance Network brings clinical research more fully into community-based healthcare settings and engages community and specialist physicians. This approach expands clinical trial access and empowers patients to advance health equity while supporting recruitment.

Winners of the 2023 and 2024 Eagle Award by Society of Clinical Research Sites

The SCRS Eagle Award recognizes the sponsor and CRO committed to outstanding leadership, professionalism, integrity, passion and dedication to advancing the clinical research profession through strong site partnerships. Recipients of the Eagle Award are selected based on votes cast from the global site community. This recognition reaffirms our commitment to collaborating with sites, which is crucial for accelerating drug development and ultimately benefiting patients. Receiving this award two years in a row is a reflection of the efforts and innovative spirit of our global site-facing and site-supporting team.

Supporting sites through customized training and continuous communication 

We understand the importance of engaging with sites early by providing study start-up tool kits and engaging investigator meetings to drive recruitment. 

Continuing with supporting the retention of sites by providing high quality, relevant and engaging follow-on training and strategic communications, with adaptive tools and materials throughout the study. 

We recognize that no two studies are the same and tailor our training and materials to the specific needs of the sites for every study.